| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |